DENTSPLY Sirona Inc (XRAY) concluded trading on Wednesday at a closing price of $13.68, with 4.98 million shares of worth about $68.1 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -41.76% during that period and on May 07, 2025 the price saw a gain of about 2.32%. Currently the company’s common shares owned by public are about 198.80M shares, out of which, 197.96M shares are available for trading.
Stock saw a price change of -1.58% in past 5 days and over the past one month there was a price change of 3.32%. Year-to-date (YTD), XRAY shares are showing a performance of -27.92% which decreased to -51.64% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $12.16 but also hit the highest price of $29.13 during that period. The average intraday trading volume for DENTSPLY Sirona Inc shares is 3.15 million. The stock is currently trading 2.32% above its 20-day simple moving average (SMA20), while that difference is down -6.47% for SMA50 and it goes to -32.36% lower than SMA200.
DENTSPLY Sirona Inc (NASDAQ: XRAY) currently have 198.80M outstanding shares and institutions hold larger chunk of about 100.35% of that.
The stock has a current market capitalization of $2.73B and its 3Y-monthly beta is at 0.92. It has posted earnings per share of -$4.55 in the same period. It has Quick Ratio of 0.74 while making debt-to-equity ratio of 1.17. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for XRAY, volatility over the week remained 2.83% while standing at 4.37% over the month.
Stock’s fiscal year EPS is expected to rise by 7.74% while it is estimated to increase by 12.46% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Morgan Stanley on April 15, 2025 offering an Equal-weight rating for the stock and assigned a target price of $14 to it. On February 14, 2025, Wells Fargo Initiated their recommendations, while on January 23, 2025, Jefferies Downgrade their ratings for the stock with a price target of $20. Stock get an In-line rating from Evercore ISI on January 07, 2025.
